Literature DB >> 2892436

Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia.

O A Meretoja1, K Wirtavuori, P J Neuvonen.   

Abstract

The effect of age on the log-based cumulative dose-response curve of vecuronium was determined in ten age groups of 80 pediatric patients ranging from neonates to adolescents during thiopental-fentanyl-N2O/O2 anesthesia. Neuromuscular block was recorded as the evoked thenar electromyographic response to train-of-four stimulation of the ulnar nerve (2 Hz at 20-second intervals). The dose-response curves were parallel to each other in all ten age groups studied. In neonates and infants, the ED95 of vecuronium was 47 +/- 11 (SD) micrograms/kg. This was significantly lower than the ED95 of 81 +/- 12 micrograms/kg in children between 3 and 10 years of age (P less than 0.01). In patients aged 13 years or older, the ED95 was 55 +/- 12 micrograms/kg, which did not differ from the neonatal and infant values but was significantly lower than the ED95 of children between 3 and 10 years of age. The results indicate that the dose of vecuronium necessary for tracheal intubation is age-dependent. The individual ED95 values varied between 22 and 103 micrograms/kg. This suggests that an individually optimal dose of vecuronium can be administered to pediatric patients only if neuromuscular block is adequately monitored.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2892436

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Vecuronium is more potent in Montreal than in Paris.

Authors:  P Fiset; F Donati; P Balendran; C Meistelman; E Lira; D R Bevan
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

2.  Effects of age on neuromuscular blockade by vecuronium as measured by accelography under sevoflurane anesthesia.

Authors:  T Kitajima; K Ishii; H Ogata
Journal:  J Anesth       Date:  1996-03       Impact factor: 2.078

3.  Pharmacokinetics of pipecuronium in infants, children and adults.

Authors:  E Tassonyi; J F Pittet; C N Schopfer; J C Rouge; G Gemperle; O H Wilder-Smith; D R Morel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jul-Sep       Impact factor: 2.441

4.  Mivacurium infusion requirements following vecuronium: different response between adults and children.

Authors:  W Denman; N Goudsouzian
Journal:  Can J Anaesth       Date:  1995-07       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.